Difference between revisions of "Li X, et al. Immunol. Lett. (2017) cited as Ref 716 in DOI: 10.1038/s41392-020-0110-5 (Q9979)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2017, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Immunol. Lett., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Immunol. Lett. | ||
| Property / Published In Name String: Immunol. Lett. / rank | |||
| + | Normal rank | ||
Revision as of 21:10, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Li X, et al. Immunol. Lett. (2017) cited as Ref 716 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Li X
0 references
2017
0 references
Immunol. Lett.
0 references
